2013
DOI: 10.3389/fimmu.2013.00338
|View full text |Cite
|
Sign up to set email alerts
|

IRAK4 and TLR3 Sequence Variants may Alter Breast Cancer Risk among African-American Women

Abstract: Mounting evidence suggests that imbalances in immune regulation contribute to cell transformation. Women of African descent are an understudied group at high risk for developing aggressive breast cancer (BrCa). Therefore, we examined the role of 16 innate immune single nucleotide polymorphisms (SNPs) in relation to BrCa susceptibility among 174 African-American women in Atlanta, GA, USA. SNPs were examined in germ-line DNA collected from 102 BrCa patients and 72 women with benign nodules using SNPstream method… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 48 publications
1
11
0
Order By: Relevance
“…Our results were consistent with a previous study which found that rs4251545 was associated with 1.68- to 4.99-fold increases in the risk of developing breast cancer in African-American women [ 16 ]. Moreover, rs4251545 locus occurred in an enhancer/silencer region of the gene, which might impact IRAK4 transcriptional level.…”
Section: Discussionsupporting
confidence: 93%
“…Our results were consistent with a previous study which found that rs4251545 was associated with 1.68- to 4.99-fold increases in the risk of developing breast cancer in African-American women [ 16 ]. Moreover, rs4251545 locus occurred in an enhancer/silencer region of the gene, which might impact IRAK4 transcriptional level.…”
Section: Discussionsupporting
confidence: 93%
“…it has previously been reported that Tlr3 sequence variants may reduce 82% of breast cancer risk among african-american women (29), and the activation of Tlr3 was associated with a significant decrease in the risk of metastatic relapse in 194 patients with breast cancer, suggesting an association between clinical outcome and Tlr3 expression (26). This is consistent with the results of the present study, which revealed lower levels of Tlr3 expression in more malignant subtypes.…”
Section: Discussionmentioning
confidence: 96%
“…SNPs affecting TLR3 have been shown to influence prognosis in cohorts of 582 patients with CRC, especially among untreated individuals with Stage II disease ( 115 ) and 568 NSCLC patients ( 116 ). Along similar lines, TLR3 SNPs have been associated with an altered risk for cervical cancer amongst 330 Tunisian women ( 117 ), breast carcinoma amongst 174 African-American women ( 118 ), oral squamous cell carcinoma amongst 197 individuals ( 119 ) HCC amongst 948 subjects ( 120 ), and CRC amongst more than 5,000 individuals ( 121 ). A type I IFN-related transcription signature centered around the expression of MX dynamin-like GTPase 1 ( MX1 ) has been shown to predict the likelihood of 50 breast carcinoma patients to respond to neo-adjuvant anthracycline-based chemotherapy ( 39 ).…”
Section: Type I Ifn and Tlr3 Signalingmentioning
confidence: 92%